Kentaro Oniki

1.7k total citations
87 papers, 1.1k citations indexed

About

Kentaro Oniki is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Kentaro Oniki has authored 87 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Cardiology and Cardiovascular Medicine and 16 papers in Epidemiology. Recurrent topics in Kentaro Oniki's work include Liver Disease Diagnosis and Treatment (13 papers), Alcohol Consumption and Health Effects (12 papers) and Hormonal Regulation and Hypertension (8 papers). Kentaro Oniki is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Alcohol Consumption and Health Effects (12 papers) and Hormonal Regulation and Hypertension (8 papers). Kentaro Oniki collaborates with scholars based in Japan, United States and China. Kentaro Oniki's co-authors include Kazuko Nakagawa, Junji Saruwatari, Ayami Kajiwara, Kazunori Morita, Shuichi Mihara, Yasuhiro Ogata, Toru Marubayashi, Masaharu Hori, Takateru Ishitsu and Seiji Hokimoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kentaro Oniki

84 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kentaro Oniki Japan 20 236 227 214 189 163 87 1.1k
Junji Saruwatari Japan 22 230 1.0× 259 1.1× 212 1.0× 182 1.0× 220 1.3× 108 1.4k
Chien-Hsiun Chen Taiwan 17 303 1.3× 300 1.3× 125 0.6× 114 0.6× 107 0.7× 41 1.4k
Joshua C. Bis United States 21 253 1.1× 411 1.8× 278 1.3× 259 1.4× 47 0.3× 53 1.6k
Katrin Borucki Germany 19 104 0.4× 233 1.0× 167 0.8× 92 0.5× 44 0.3× 50 997
Britt-Marie Loo Finland 24 282 1.2× 373 1.6× 233 1.1× 236 1.2× 159 1.0× 43 1.4k
Gerjan Navis Netherlands 22 270 1.1× 275 1.2× 93 0.4× 311 1.6× 104 0.6× 60 1.4k
Minkyung Oh South Korea 19 157 0.7× 137 0.6× 111 0.5× 113 0.6× 91 0.6× 94 1.2k
Jonathan Blau United States 10 174 0.7× 175 0.8× 127 0.6× 333 1.8× 206 1.3× 21 1.1k
Pär Hallberg Sweden 18 148 0.6× 137 0.6× 96 0.4× 279 1.5× 104 0.6× 62 1.1k
Jessica Faulkner United States 24 377 1.6× 271 1.2× 177 0.8× 289 1.5× 515 3.2× 62 1.9k

Countries citing papers authored by Kentaro Oniki

Since Specialization
Citations

This map shows the geographic impact of Kentaro Oniki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Oniki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Oniki more than expected).

Fields of papers citing papers by Kentaro Oniki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Oniki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Oniki. The network helps show where Kentaro Oniki may publish in the future.

Co-authorship network of co-authors of Kentaro Oniki

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Oniki. A scholar is included among the top collaborators of Kentaro Oniki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Oniki. Kentaro Oniki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomita, Tetsu, Miki Nishimura, Tetsuya Kaneko, et al.. (2025). Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic‐Pharmacodynamic and Machine Learning Analyses. CPT Pharmacometrics & Systems Pharmacology. 14(6). 1119–1127. 1 indexed citations
2.
Saruwatari, Junji, Tetsu Tomita, Shoko Tsuchimine, et al.. (2025). A MODELING APPROACH TO THE THERAPEUTIC EFFECT OF PAROXETINE FOR DEPRESSION WITH A FOCUS ON PHARMACOKINETICS- PHARMACODYNAMICS RELATIONSHIP. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i189–i190.
3.
Fukuda, Ryo, Yukio Fujiwara, Hitoshi Maeda, et al.. (2025). Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages. Molecular Cancer. 24(1). 132–132. 1 indexed citations
4.
Kagimura, Tatsuo, Kaoru Omae, Akiko Tanaka, et al.. (2024). Characteristics and Transition of Sleep–Wake Rhythm in Nursery School Children: The Importance of Nocturnal Sleep. SHILAP Revista de lepidopterología. 6(4). 668–681. 2 indexed citations
5.
Oniki, Kentaro, Kayoko Ohura, Teruya Nakamura, et al.. (2024). The Association of the Cholesterol Efflux Capacity with the <i>Paraoxonase 1</i> Q192R Genotype and the Paraoxonase Activity. Journal of Atherosclerosis and Thrombosis. 31(9). 1263–1276. 2 indexed citations
6.
Oniki, Kentaro, Masatsune Ogura, Hiroshi Watanabe, et al.. (2024). Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction. Journal of Atherosclerosis and Thrombosis. 31(8). 1149–1161. 2 indexed citations
7.
Ishida, Toshifumi, Yuichiro Arima, Yuji Mizuno, et al.. (2021). East Asian variant aldehyde dehydrogenase type 2 genotype exacerbates ischemia/reperfusion injury with ST-elevation myocardial infarction in men: possible sex differences. Heart and Vessels. 37(2). 184–193. 6 indexed citations
8.
Hamada, Shinsuke, et al.. (2021). Comparison between the Effects of Loxoprofen and Acetaminophen on Postoperative Pain Following Radical Prostatectomy: A Propensity Score Matching Analysis. Biological and Pharmaceutical Bulletin. 44(10). 1427–1432. 4 indexed citations
9.
Inazumi, Tomoaki, Kiyotaka Yamada, Naritoshi Shirata, et al.. (2020). Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance. Cell Reports. 33(2). 108265–108265. 42 indexed citations
10.
Oniki, Kentaro, Yuki Sakamoto, Tadashi Imafuku, et al.. (2020). The DsbA-L gene is associated with respiratory function of the elderly via its adiponectin multimeric or antioxidant properties. Scientific Reports. 10(1). 5973–5973. 13 indexed citations
11.
Nishimura, Miki, Junji Saruwatari, Akiko Aoki, et al.. (2016). Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder. Pharmacogenetics and Genomics. 26(9). 403–413. 2 indexed citations
12.
Morita, Kazunori, Junji Saruwatari, Takahiro Tanaka, et al.. (2016). Common variants of HNF1A gene are associated with diabetic retinopathy and poor glycemic control in normal-weight Japanese subjects with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 31(2). 483–488. 3 indexed citations
13.
Oniki, Kentaro, Miki Nishimura, Kazuki Matsuda, et al.. (2015). Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis. PLoS ONE. 10(10). e0141266–e0141266. 30 indexed citations
14.
15.
Saruwatari, Junji, et al.. (2014). Effects of Seijo‐bofu‐to, a Traditional Japanese Herbal Medicine Containing Furanocoumarin Derivatives, on the Drug‐Metabolizing Enzyme Activities in Healthy Male Volunteers. Basic & Clinical Pharmacology & Toxicology. 115(4). 360–365. 8 indexed citations
16.
Morita, Kazunori, Hiroko Miyazaki, Junji Saruwatari, et al.. (2014). Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients. Toxicology Letters. 232(1). 221–225. 13 indexed citations
17.
Kajiwara, Ayami, Junji Saruwatari, Kentaro Oniki, et al.. (2013). Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy. Pharmacogenetics and Genomics. 23(12). 717–720. 9 indexed citations
18.
Oniki, Kentaro, Masaharu Hori, Junji Saruwatari, et al.. (2013). Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. Toxicology Letters. 220(2). 143–149. 19 indexed citations
19.
20.
Oniki, Kentaro, Yuichiro Umemoto, Rie Nagata, et al.. (2008). Glutathione S-transferase A1 polymorphism as a risk factor for smoking-related type 2 diabetes among Japanese. Toxicology Letters. 178(3). 143–145. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junji Saruwatari Breakdown of academic impact, for papers by Chien-Hsiun Chen Breakdown of academic impact, for papers by Joshua C. Bis Breakdown of academic impact, for papers by Katrin Borucki Breakdown of academic impact, for papers by Britt-Marie Loo Breakdown of academic impact, for papers by Gerjan Navis Breakdown of academic impact, for papers by Minkyung Oh Breakdown of academic impact, for papers by Jonathan Blau Breakdown of academic impact, for papers by Pär Hallberg Breakdown of academic impact, for papers by Jessica Faulkner
Rankless by CCL
2026